Renal Disease Overview

Principles

Definition

Renal disease is a comprehensive domain within biomedical science and clinical medicine dedicated to investigating the diverse conditions that impair kidney structure and function, encompassing their etiology, pathogenesis, diagnosis, treatment, and prevention. This field employs multidisciplinary approaches to elucidate disease mechanisms, assess clinical manifestations, and develop therapeutic strategies aimed at preserving renal function and improving patient outcomes.

Ontological type

Pathophysiological Mechanisms

Therapeutic Strategies

Diagnostic Approaches

Key developments

Key Figures

Physiology and Renal Replacement era

Jacob Churg [1] was active at Albert Einstein College of Medicine [3] and Icahn School of Medicine at Mount Sinai [4] during this era. His key contribution in this era stems from the 1970 paper PATHOLOGY OF THE NEPHROTIC SYNDROME IN CHILDREN [7], which advanced the understanding of pediatric nephrotic pathology and prognosis. Robert L. Vernier [2] was affiliated with University of California, Los Angeles [5] and University of Minnesota [6] during this era. His notable contribution is the 1957 electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus [8], which provided detailed structural insights that helped frame mechanistic interpretations of glomerular disease in this era.

Morphology and Hemodynamics era

Andrew S. Levey [1] emerged as a leading figure in the Morphology and Hemodynamics era, with affiliations at Harvard University [3] and University of California, San Francisco [4]. Levey [1] helped anchor CKD taxonomy through landmark documents—the National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification [6], the KDIGO Definition and Classification of Chronic Kidney Disease [7], and the framework for Assessing Kidney Function via Measured and Estimated Glomerular Filtration Rate [8]—which standardized evaluation, risk stratification, and guided therapeutic decision-making in this era. Josef Coresh [2] contributed to the era's epidemiologic and methodological foundation with roles at University of California, San Francisco [4] and Johns Hopkins University [5], shaping population-level CKD assessment through guidelines [6], KDIGO statements [7], and GFR measurement approaches [8]. Thus, Coresh [2] reinforced the era's morphologic-hemodynamic aims by promoting cross-institutional comparability of kidney-function metrics across University of California, San Francisco [4] and Johns Hopkins University [5], enabling consistent guideline implementation and risk stratification [6][7][8].

Precision and Computational Nephrology era

Sanjeev Sethi[1] is a leading nephrology scholar aligned with Washington University in St. Louis[3] and Cornell University[4] during the Precision and Computational Nephrology era. His key contributions include shaping the KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases[7] and the Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices[8], which advanced harmonized diagnostic criteria and risk-based management essential for precision nephrology. Zhihong Liu[2] is a prominent figure associated with Rockefeller University[5] and the Center for Life Sciences[6] in this era. Her work on the KDIGO guideline collaboration[7] and on Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy[9] exemplifies integrating large-scale risk stratification into nephrology practice, a core aim of precision and computational nephrology.